FDA approves GW Pharmaceuticals’ cannabis drug for new indication
CBD drug Epidiolex received approval from the U.S. Food and Drug Administration to treat seizures associated with a…
News August 3
Latest In: Dravet syndrome
European Commission approves Epidiolex marketing authorization, GW Pharmaceuticals says
The European Commission granted marketing authorization to Epidyolex, the trade name in Europe for Epidiolex, GW Pharmaceuticals announced Monday. In…
News September 23
South Korea’s medical cannabinoid law to go into effect in March
A groundbreaking law legalizing medical cannabis in South Korea that takes effect March 12 will pave the way for the…
News February 19
Sponsored
The New Genetics Race: Why Cannabis Seed Brands Are Becoming the Next Big Differentiator
As cannabis shoppers become more educated, seed brands are no longer just selling genetics — they are shaping loyalty, discovery, and the next wave of premium cultivation culture.
June 9
Featured
1
Latest Sponsored
